Navigation Links
New Breast Cancer Test Could Save Lives

A team of researchers at the University of Bristol is developing a revolutionary new test to detect breast cancer at an early stage. If successful, this test will be effective for women of all ages; given that breast cancer is the largest killer of women between the ages of 35-55 in Europe, the test could have a dramatic effect on the number of deaths from this disease.

The test, which utilises an innovative radar system, will enable women to be tested regularly without the fear of over-exposure to radiation, a problem with existing X-ray tests. Currently, in order to detect cancer at an early stage ?which is extremely important for successful treatment - many women are dependent on self-examination which can prove unreliable. This latest technology has the ability to image through dense breast tissue, and therefore can reach a far wider section of women than X-ray mammography can.

Women below 50 in particular will benefit from this new test, which is much more reliable than X-rays at detecting cancer in this age group. The test is also a much more comfortable procedure than X-rays since it does not involve compressing the breast between plates. This could encourage many more women to be tested regularly for breast cancer, which, according to Cancer Research UK, is the most common cancer for women in this country.

Alan Preece, Professor of Medical Physics at the University of Bristol and one of the lead scientists on this project, said: “Breast cancer is one of the biggest killers that women currently face. Each year, there are over 41,000 new cases in the UK alone. We are very excited about this new technology and the benefits that might come from its use.?/p>

This world-leading research project is funded by the United Bristol Healthcare Trust (UBHT), the University of Bristol’s enterprise initiative and the Sulis Seedcorn fund, which recently awarded over £100,000 of venture capital to the project. Commercialisation of the project has be
'"/>

Source:Bristol University


Page: 1 2

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
3. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
4. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
5. Breast Cancer May Be Uniquely Sensitive To Inhibitors Of PI3K Pathway
6. Breast-Cancer Risk Linked to Exposure to Traffic Emissions at Menarche, First Birth
7. Nanoparticle Breast Cancer Drug Approved by FDA
8. Genpathway and Baylor College of Medicine Identify New Genes in Breast Cancer
9. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
10. Affymetrix and bioMerieux Extend Their Agreement on GeneChip(R) Technology to Breast Cancer Diagnostics
11. Antiretroviral Therapy May Prevent HIV Transmission From Breastfeeding Mothers To Infants

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Breast Cancer Test Could Save Lives

(Date:11/23/2009)... Hampshire microbiologist Louis Tisa has received ...ing of the actinorhizal plants, widespread woody p...ontaminated soils. , The United States Departme... of molecular, cellular and biomedical sciences, $...een the bacteria Frankia and Casuarina, an actinor...
(Date:11/23/2009)... , , , , , , , ... Dr Andrew Marshall, from the Environment Departme...ery of Kinyongia magomberae and his wider work i...re information. , , , , , ... , , , , , , A new species of chamel...
(Date:11/23/2009)...ector of the Interuniversity Professorship in Law ... University of the Basque Country. The Professorsh...r experts such as researchers in the fields of mol...thics. , The Interuniversity Professorship in La...sto and the Basque Country was created in 1993. Th...
Breaking Biology News(10 mins):UNH prof. receives nearly $500,000 to research environmentally significant plants 2New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3Research and legislation should go hand in hand, as much as possible 2Stryker Announces Agreements To Acquire Assets 6148 1Stryker Announces Agreements To Acquire Assets 6148 2Stryker Announces Agreements To Acquire Assets 6148 3Transcept Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference on November 17 6146 1Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 1Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 2Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 3Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 4Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 5Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 6
...by a University of Houston professor will be featu... Summit Research Conference July 28. , Kurt L. Kra...istry at UH, will give a presentation at 11 a.m. o...." , Sponsored by the Nanotechnology Foundation o...or Texas natural science, engineering and medical ...
...have identified a previously unknown family of vir... for the plague especially efficient at killing it...trated that the use of the common roundworm is a v...pestis, the bacterium that causes plague. They als...d the worm is quite similar to what occurs in mamm...
...have identified a previously unknown family of vir... for the plague especially efficient at killing it...trated that the use of the common roundworm is a v...pestis, the bacterium that causes plague. They als...d the worm is quite similar to what occurs in mamm...
Other Biology News:Disease diagnosis, bioengineering covered at state nano summit 2New Look at DNA Hints at Origin of UV Damage 2New Look at DNA Hints at Origin of UV Damage 3New Look at DNA Hints at Origin of UV Damage 4Novel plague virulence factor identified 2Novel plague virulence factor identified 3Novel plague virulence factor identified 4
(Date:11/23/2009)...GA,ON,Nov.23/PRNewswire-FirstCall/-YMBioSciencesIn...lopmentcompanythatidentifiesandadvancesadiversepor...agesofdevelopment,todayreportedthatCytopia(ASX:CYT...CYT387,apotent,orally-administeredJAK1/JAK2inhibit...,Minnesota.AproposaltomergeCytopiaintoYMhasbeenpre...
(Date:11/23/2009)...C,Nov.23/PRNewswire/-InimexPharmaceuticals,Inc.ann...sitsPresidentandCEO. ,, Abramsbringsmorethan25y...x.Heisaco-inventorofthenuclearmedicineimagingagent...y,plcwherehewasManager,BiomedicalResearchWorldwide...y,BCandwasPresidentandCEOfrom1996to2006.AnorMEDdis...
(Date:11/20/2009)... , , , , , , , ... AUDIO: , A team of scientists from Washing...zona, Cold Spring Harbor Laboratory and Iowa State...n. The... , , Click here for more... , , , , , , , ...
(Date:11/20/2009)...VILLE, Md., Nov. 20 Nova... has priced an underwritten public offering of 6,8...e public of $3.30 per share. The approximately $2...erwriting discounts and commissions, will be used ... VLP-based vaccines, internal research and develop...
Breaking Biology Technology:YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Inimex Announces Appointment of New CEO 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Novavax Prices Public Offering of Common Stock 2
...e Board of,Directors of Shire plc (LSE: SHP) (NASD...al company, announces today that Michael Rosenblat...ctor with immediate effect., Dr Rosenblatt is the...n, Massachusetts. He was previously Professor of M...n senior research positions at the Beth,Israel Dea...
...,Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announ...ical Officer of BioMarin, will present a,company u...ugged Conference,in Key Biscayne, Florida on Thurs...ties may access a live audio webcast of the presen...bsite, http://www.BMRN.com . A,replay of the pres...
...r,BioTherapeutics, Inc. (OTC Bulletin Board: CVBTE...rey Jr. to form Cardio Derma Clinical Partners,(CD...general partner, will,fund a minimum of $1,000,000...of CVBT,s wound healing drug candidate., "R&D Par...by some of,today,s biggest names in biotechnology ...
Other Biology Technology:Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 2Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 3Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 4BioMarin to Present at the Morgan Stanley Healthcare Conference 2CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership 2CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership 3
...far-infrared range FT-IR spectrometers give you th...lass. Yet all this comes at an amazingly affordabl...ving a larger and faster mirror closer to the sour...300%,larger solid angle of energy into the interfe...
... measure three fluorescence lifetimespicoseconds t...es. To match the absorption maxima of the amino ac...xcitation source is the powerful NanoLED-17, a pul...han is widely used as a probe of protein structure...
...were designed for full-length gene cloning and req...ed cDNA clone. The first PCR analysis is performed...ains plasmid DNA from 5,000 clones. Having identif... the reaction products, the second PCR analysis is...
...were designed for full-length gene cloning and req...ed cDNA clone. The first PCR analysis is performed...ains plasmid DNA from 5,000 clones. Having identif... the reaction products, the second PCR analysis is...
Biology Products: